PMID: 6400706Sep 1, 1983Paper

The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration

Diabetes Care
P HildebrandtS L Nielsen

Abstract

The effect of injection technique on the absorption of subcutaneously injected short-acting insulin [125I-labeled Actrapid (MC), Novo, Copenhagen, Denmark] was investigated in insulin-dependent diabetic patients. In one side of the abdomen insulin was given with a fixed standard technique. In the other side of the abdomen the temperature of the injected insulin, the depth of injection, and the duration of injection were varied. Furthermore, we compared the absorption of U40 and U100 insulin by giving either 8 U of the two insulins or 0.1 ml of both insulins simultaneously to the patients in either side of the abdomen. With regard to the injection technique the only significant finding was a faster absorption rate with deep (12 mm) than with superficial (3 mm) injection. The absorption of U100 insulin was significantly slower than of U40 insulin, when given in the same amount (8 U) as well as in the same volume (0.1 ml).

Citations

Apr 1, 1993·Diabetes/metabolism Reviews·S A Amiel
Jan 5, 2002·Diabetes Technology & Therapeutics·M K FrohnauerJ H Anderson
Feb 24, 2007·Diabetes Technology & Therapeutics·Reinhard H A Becker
Dec 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·C M Houtzagers
May 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·A VaagH Beck-Nielsen
Jul 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·P H de MeijerA van't Laar
Jan 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·B GrønlundS Madsbad
Apr 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·A Frid, B Linde
Sep 1, 1993·Biomedizinische Technik. Biomedical Engineering·Z TrajanoskiF Skraba
Jul 24, 2012·Therapeutic Delivery·Henryk MachMohammed Shameem
Jun 13, 2013·Computer Methods and Programs in Biomedicine·Zimei WuStephen Chang
Nov 26, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tue SøeborgMorten Colding-Jørgensen
Jun 11, 2003·Diabetes, Obesity & Metabolism·Jian-Wen ChenTorsten Lauritzen
Aug 1, 1993·Diabetes Research and Clinical Practice·A Frid, B Linde
Nov 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·S M Furler, E W Kraegen
Jul 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·P Hildebrandt, K Birch
Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·F H ZielC S Rosenberg
Jul 1, 1987·Diabetes Research and Clinical Practice·P J WahabR J Heine
May 25, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Alamdar Hussain, Fakhrul Ahsan
Aug 26, 2017·Advanced Healthcare Materials·Naveed A BakhMichael S Strano
May 1, 1985·Diabetic Medicine : a Journal of the British Diabetic Association·R J HeineE A van der Veen
Sep 1, 1984·Diabetic Medicine : a Journal of the British Diabetic Association·J J Bending, B Griffiths
Sep 1, 1991·Indian Journal of Pediatrics·J T Jørgensen, S Susgaard
Jun 7, 2012·Clinical Pharmacokinetics·Miroslav DostalekMartina Puzanovova
Dec 25, 2007·Arquivos brasileiros de endocrinologia e metabologia·Frederico G MarchisottiBerenice B Mendonça

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.